BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1238133)

  • 1. Proceedings: Interaction of carbenoxolone sodium with other drigs bound to plasma proteins.
    Gottfried S; Parke DV; Sacra PJ; Thornton PC
    Br J Pharmacol; 1975 Oct; 55(2):252P-253P. PubMed ID: 1238133
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship with adverse drug effects.
    Hayes MJ; Sprackling M; Langman MJ
    Gut; 1977 Dec; 18(12):1054-8. PubMed ID: 606633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and qualitative aspects of the plasma protein binding of carbenoxolone, an ulcer-healing drug.
    Parke DV; Lindup WE
    Ann N Y Acad Sci; 1973 Nov; 226():200-13. PubMed ID: 4203419
    [No Abstract]   [Full Text] [Related]  

  • 4. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein binding of a novel cardioprotective drug, stobadin.
    Koprda V; Oravcová J
    Pharmazie; 1989 Dec; 44(12):869. PubMed ID: 2635325
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbenoxolone interactions in man--preliminary report.
    Thornton PC; Papouchado M; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():35-9. PubMed ID: 6937939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Large differences between human and bovine serum albumin reflected in the binding behaviour for benzodiazepine derivatives, circular dichroism and gelfiltration studies.
    Müller W; Wollert U
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R68. PubMed ID: 4276619
    [No Abstract]   [Full Text] [Related]  

  • 8. An analysis of the effect of hypoalbuminemia on the amount of free drug in plasma for drugs bound at two sets of sites.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):681-8. PubMed ID: 4456500
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: A comparison of the interactions of pyrantel and morantel with serum albumins.
    Bababunmi EA; Bamgbose SO
    West Afr J Pharmacol Drug Res; 1974 Dec; 2(1):93P. PubMed ID: 4478955
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigating noncovalent interactions of rutin-serum albumin by capillary electrophoresis-frontal analysis.
    Lu QH; Ba CD; Chen DY
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):888-91. PubMed ID: 18436413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioimmunoassay for carbenoxolone].
    Peskar BM; Wachter W; Heissmeyer H; Gerok W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1717-9. PubMed ID: 611917
    [No Abstract]   [Full Text] [Related]  

  • 12. Optical studies of drug-protein complexes. 3. Interaction of flufenamic acid and other N-arylanthranilates with serum albumin.
    Chignell CF
    Mol Pharmacol; 1969 Sep; 5(5):455-62. PubMed ID: 5823761
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereoselective plasma protein binding of amlodipine.
    Maddi S; Yamsani MR; Seeling A; Scriba GK
    Chirality; 2010 Feb; 22(2):262-6. PubMed ID: 19496159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characterization of propofol binding to plasma proteins and possible interactions].
    Garrido MJ; Jiménez RM; Rodríguez-Sasiaín JM; Aguirre C; Aguilera L; Calvo R
    Rev Esp Anestesiol Reanim; 1994; 41(6):308-12. PubMed ID: 7838996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of free fatty acid concentration on the transport and utilization of other albumin-bound compounds: hydroxyphenylazobenzoic acid.
    Spector AA; Imig B
    Mol Pharmacol; 1971 Sep; 7(5):511-8. PubMed ID: 5139562
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor drug-protein interactions. Binding of 1-beta-D-arabinofuranosyl cytosine to albumin and chemically modified albumin.
    Szekerke M; Horváth M; Hudecz F
    Arzneimittelforschung; 1979; 29(1):19-21. PubMed ID: 36105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectroscopic studies on the interaction of a water-soluble cationic porphyrin with proteins.
    Ma HM; Chen X; Zhang N; Han YY; Wu D; Du B; Wei Q
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Apr; 72(3):465-9. PubMed ID: 19054710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative binding studies of anticonvulsant drugs to bovine serum albumin.
    Dal Pozzo A; Acquasaliente M; Tajana A
    Farmaco Sci; 1983 Aug; 38(8):609-18. PubMed ID: 6617856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of myristic acid on furosemide binding to bovine serum albumin. Comparison with furosemide-human serum albumin complex.
    Bojko B; Sułkowska A; Maciazek-Jurczyk M; Równicka J; Sułkowski WW
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Jun; 76(1):6-11. PubMed ID: 20308015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of the phosphorothioate insecticides chlorpyrifos and parathion and their oxygen analogues with bovine serum albumin.
    Sultatos LG; Basker KM; Shao M; Murphy SD
    Mol Pharmacol; 1984 Jul; 26(1):99-104. PubMed ID: 6205248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.